Glazer Capital LLC’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Glazer Capital LLC’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,412,219	Closed	-$96.2M	–	801
2022 Q3	$96.2M	Buy	+1,412,219	New	+$77.9M	1.76%	5

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's GBT Position: Q4 2022 in Review

Glazer Capital LLC sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 1,412,219 shares — an estimated $96.2M sold.

Glazer Capital LLC first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $96.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Glazer Capital LLC reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 1,412,219 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $96.2M.
Glazer Capital LLC first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Glazer Capital LLC's Global Blood Therapeutics, Inc. position peaked at $96.2M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.